STAAR SURGICAL CO·4

Jun 22, 4:05 PM ET

Jiang Wei 4

Research Summary

AI-generated summary

Updated

STAAR (STAA) Director Jiang Wei Receives Award, Converts RSUs

What Happened
Jiang Wei, a director of STAAR Surgical (STAA), had 10,683 derivative units convert/vest on June 18, 2026 (reported as both acquired and disposed at $0.00) and was granted 6,182 restricted stock units (RSUs) the same day at $0.00. The conversion/transaction shows no cash value in the filing; the new RSU award is part of the company’s annual non-employee director equity program. These transactions are compensation-related rather than an open-market purchase or sale.

Key Details

  • Transaction date(s): June 18, 2026 (all items reported at $0.00 per share).
  • 10,683 shares: reported as exercise/conversion of a derivative (code M) — shown both acquired and disposed (derivative). Footnote F1: these were RSUs granted on June 18, 2025 that vested on June 18, 2026.
  • 6,182 shares: reported as a grant/award (code A). Footnote F2: these RSUs were granted June 18, 2026 and vest in full on the earlier of June 18, 2027 or the 2027 annual meeting.
  • Shares owned after transaction: Not specified in the provided excerpt.
  • Filing timing: Form 4 filed June 22, 2026 for transactions on June 18, 2026 (filed four days after the transactions; Form 4s are typically due within two business days, so this may be later than standard).
  • Remarks: Filing states these awards are part of the issuer’s annual non-employee director equity compensation program.

Context

  • The M-code activity indicates conversion/exercise of vested derivative awards (here, vested RSUs). The matched "disposed" entry at $0.00 often reflects net settlement or shares withheld for taxes rather than an open-market sale.
  • The A-code grant is a standard director RSU award that vests in the future and is routine compensation for non-employee directors; such grants are common and don’t necessarily indicate the director’s view on the stock.